Five minutes with…Al Altomari of Agile Therapeutics
This article was originally published in Clinica
Executive Summary
Al Altomari is president and CEO of Agile Therapeutics, a privately-held Princeton, New Jersey firm targeting the $4bn contraceptive market. It is currently developing a once-weekly, low-dose combination contraceptive patch, incorporating the firm's Skinfusion transdermal delivery technology